Pulmokine, Inc.
Records under this name other than the patents Pulmokine, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to Pulmokine, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 14/760,165 | Therapeutic Indications of Kinase Inhibitors held by Gilead Sciences, Inc. Abandoned Abandoned Nov 13, 2017 | Abandoned | Abandoned Nov 13, 2017 | |
| 15/809,054 | Spray Dry Formulations held by Gilead Sciences, Inc. and Pulmokine Inc. Abandoned Abandoned Oct 29, 2019 | Abandoned | Abandoned Oct 29, 2019 | |
| 16/256,213 | Combination Therapy for Treating Pulmonary Hypertension Abandoned Abandoned Sep 23, 2019 | Abandoned | Abandoned Sep 23, 2019 | |
| 16/968,530 | Formulations of Kinase Inhibitors and Prostanoids Abandoned Abandoned Jul 8, 2024 | Abandoned | Abandoned Jul 8, 2024 | |
| 18/628,470 | Formulations of Kinase Inhibitors and Prostanoids Abandoned Abandoned Jun 8, 2026 | Abandoned | Abandoned Jun 8, 2026 |